This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
ALMOGRAN
INN: ALMOGRAN
Data updated: 2026-04-11
Available in:
🇩🇪🇬🇧🇪🇸🇫🇷
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
Almirall S.A.
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
(ES)
Source
CIMA_ES
USDailyMed:Almotriptan
N02CC05(WHO)
UK:POM(Prescription only)US:℞-onlyEU:Rx-onlyIn general: ℞ (Prescription only)
N,N-dimethyl-2- [5-(pyrrolidin-1-ylsulfonylmethyl)- 1H-indol-3-yl]-ethanamine
154323-57-6Y
123606
7110
DB00918Y
110198Y
1O4XL5SN61
D02824Yas salt:D02825Y
CHEBI:520985Y
ChEMBL1505Y
DTXSID5044289
Interactive image
CN(C)CCc2c[nH]c3ccc(CS(=O)(=O)N1CCCC1)cc23
InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3YKey:WKEMJKQOLOHJLZ-UHFFFAOYSA-NY
Almotriptan, sold under the brand namesAxertandAlmogranamong others, is atriptanmedicationused in the treatment of heavymigraine headache.
Almotriptan was patented in 1992 and approved for medical use in 2000.It was discovered and developed byAlmirall-Prodesfarma.